Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment

NAActive, not recruitingINTERVENTIONAL

Enrollment

675

Participants

Timeline

Start Date

May 30, 2020

Primary Completion Date

April 30, 2024

Study Completion Date

September 14, 2024

Conditions

IVFIntracytoplasmic Sperm Injection

Interventions

DRUG

Buscopan 20 milligrams/ML Injectable Solution

cases will be randomized to Buscopan group or Normal Saline group, injection will be given 5 minutes prior to embryo transfer

Trial Locations (1)

Prince of Wales Hospital, Hong Kong

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER